- Home
- AVB vs GEHC Comparison
AVB vs GEHC Comparison
Compare AVB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVB
- GEHC
- Stock Information
- Founded
- AVB 1978
- GEHC 1892
- Country
- AVB United States
- GEHC United States
- Employees
- AVB N/A
- GEHC N/A
- Industry
- AVB Real Estate Investment Trusts
- GEHC Computer Software: Prepackaged Software
- Sector
- AVB Real Estate
- GEHC Technology
- Exchange
- AVB Nasdaq
- GEHC Nasdaq
- Market Cap
- AVB 29.5B
- GEHC 28.1B
- IPO Year
- AVB 1994
- GEHC N/A
- Fundamental
- Price
- AVB $205.54
- GEHC $70.66
- Analyst Decision
- AVB Buy
- GEHC Strong Buy
- Analyst Count
- AVB 14
- GEHC 10
- Target Price
- AVB $237.43
- GEHC $88.80
- AVG Volume (30 Days)
- AVB 859.4K
- GEHC 6.1M
- Earning Date
- AVB 04-30-2025
- GEHC 04-30-2025
- Dividend Yield
- AVB 3.41%
- GEHC 0.20%
- EPS Growth
- AVB 19.57
- GEHC 38.77
- EPS
- AVB 8.03
- GEHC 4.76
- Revenue
- AVB $2,998,359,000.00
- GEHC $19,799,000,000.00
- Revenue This Year
- AVB $3.43
- GEHC $3.77
- Revenue Next Year
- AVB $5.38
- GEHC $4.61
- P/E Ratio
- AVB $25.53
- GEHC $14.81
- Revenue Growth
- AVB 6.12
- GEHC 1.56
- 52 Week Low
- AVB $180.40
- GEHC $57.65
- 52 Week High
- AVB $239.29
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- AVB 46.59
- GEHC 52.24
- Support Level
- AVB $206.98
- GEHC $66.95
- Resistance Level
- AVB $209.67
- GEHC $71.21
- Average True Range (ATR)
- AVB 3.68
- GEHC 2.14
- MACD
- AVB 0.22
- GEHC 1.09
- Stochastic Oscillator
- AVB 8.37
- GEHC 81.60
About AVB AvalonBay Communities Inc.
AvalonBay Communities owns a portfolio of 289 apartment communities with over 87,000 units and is developing 17 additional properties with over 6,000 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).